Treatment parameters and rationale for the use of electroconvulsive therapy for the management of treatment-refractory agitation in alzheimer's disease

Over 5.8?million people in the US are currently living with Alzheimer's disease (AD), the most common form of neurodegenerative dementia. More than 90% of individuals with AD experience neuropsychiatric symptoms (NPS), such as agitation, apathy, and depression. Agitation is one of the most common NPS, which not only accounts for 12% of health and social care costs but also increases the risk of mortality and caregiver burden. The most common treatments for agitation include psychotropic medications, used off-label, along with behavioral management strategies.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Poster Number: NR - 29 Source Type: research